Cargando…

Pregabalin Population Pharmacokinetic and Exposure‐Response Analyses for Focal Onset Seizures in Children (4–16 years) and Adults, to Support Dose Recommendations in Children

Pregabalin is approved in multiple countries as adjunctive therapy for adult patients with focal onset seizures (FOS; previously termed partial onset seizures). This study used population pharmacokinetic (PK) and exposure–response (E‐R) analyses from pooled pregabalin concentration and efficacy data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Phylinda L. S., Marshall, Scott F., McFadyen, Lynn, Liu, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359225/ https://www.ncbi.nlm.nih.gov/pubmed/33280106 http://dx.doi.org/10.1002/cpt.2132

Ejemplares similares

The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjects
por: Chan, Phylinda L. S., et al.
Publicado: (2010)

Adjunctive pregabalin vs gabapentin for focal seizures: Interpretation of comparative outcomes
por: French, Jacqueline, et al.
Publicado: (2016)

The use of extrapolation based on modeling and simulation to support high‐dose regimens of ceftaroline fosamil in pediatric patients with complicated skin and soft‐tissue infections
por: Chan, Phylinda L.S., et al.
Publicado: (2021)

Treatment of Focal-Onset Seizures in Children: Should This Be More Etiology-Driven?
por: Aeby, Alec, et al.
Publicado: (2022)

Population Pharmacokinetic Modeling and Probability of Pharmacodynamic Target Attainment for Ceftazidime‐Avibactam in Pediatric Patients Aged 3 Months and Older
por: Franzese, Richard C., et al.
Publicado: (2021)

Population Pharmacokinetics of Fosdagrocorat (PF‐04171327), a Dissociated Glucocorticoid Receptor Agonist, in Patients With Rheumatoid Arthritis
por: Weatherley, Barry, et al.
Publicado: (2017)

Computational modelling of micro-seizures and focal seizure onset
por: Wang, Yujiang, et al.
Publicado: (2013)

Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children
por: Boonsathorn, Sophida, et al.
Publicado: (2018)

Pharmacokinetics of Single-Dose Oral Pregabalin Administration in Normal Cats
por: Esteban, Michaela A., et al.
Publicado: (2018)

Efficacy and Safety of Perampanel in Children with Drug-Resistant Focal-Onset Seizures: A Retrospective Review
por: Elmardenly, Ahmed, et al.
Publicado: (2023)

Correction to: Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children
por: Boonsathorn, Sophida, et al.
Publicado: (2018)

No Clinical Impact of CYP3A5 Gene Polymorphisms on the Pharmacokinetics and/or Efficacy of Maraviroc in Healthy Volunteers and HIV‐1–Infected Subjects
por: Vourvahis, Manoli, et al.
Publicado: (2018)

Dynamic Mechanisms of Neocortical Focal Seizure Onset
por: Wang, Yujiang, et al.
Publicado: (2014)

Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures
por: Lattanzi, Simona, et al.
Publicado: (2022)

Efficacy of Pregabalin in Childhood Refractory Partial Seizure
por: Zamani, Gholamreza, et al.
Publicado: (2014)

Patient considerations in the management of focal seizures in children and adolescents
por: Kenney, Daniel, et al.
Publicado: (2014)

Focal and generalized onset seizures in children post-COVID (Omicron) recovery: 3 clinical case reports
por: Bechor Ariel, Tal, et al.
Publicado: (2023)

Pharmacokinetics of single and repeated oral doses of pregabalin oral solution formulation in cats
por: Lamminen, Terttu, et al.
Publicado: (2022)

Mechanisms underlying different onset patterns of focal seizures
por: Wang, Yujiang, et al.
Publicado: (2017)

Incidence of CXCR4 tropism and CCR5-tropic resistance in treatment-experienced participants receiving maraviroc in the 48-week MOTIVATE 1 and 2 trials
por: Jubb, Becky, et al.
Publicado: (2019)

Clinical pharmacokinetics and dose recommendations for posaconazole gastroresistant tablets in children with cystic fibrosis
por: Bentley, Siân, et al.
Publicado: (2021)

Intracortical neural activity distal to seizure-onset-areas predicts human focal seizures
por: Proix, Timothée, et al.
Publicado: (2019)

Brivaracetam: a novel antiepileptic drug for focal-onset seizures
por: Stephen, Linda J., et al.
Publicado: (2017)

A model for focal seizure onset, propagation, evolution, and progression
por: Liou, Jyun-you, et al.
Publicado: (2020)

Temporal Onset Focal Seizures Induced by Intermittent Photic Stimulation
por: Niu, Yue, et al.
Publicado: (2021)

Behavioral presentations of focal onset seizures: A case series
por: Maggu, Gaurav, et al.
Publicado: (2021)

Pharmacokinetic studies in children: recommendations for practice and research
por: Barker, Charlotte I S, et al.
Publicado: (2018)

Pharmacokinetic equivalence study of two formulations of the anticonvulsant pregabalin
por: Tjandrawinata, Raymond R, et al.
Publicado: (2015)

Structural covariance networks relate to the severity of epilepsy with focal-onset seizures
por: Drenthen, Gerhard S., et al.
Publicado: (2018)

Genetic generalized epilepsy and generalized onset seizures with focal evolution (GOFE)
por: Lamy, Florian, et al.
Publicado: (2022)

Perampanel as First Adjunctive Treatment in Patients with Focal-Onset Seizures in the FAME Study: Post hoc Analyses of Dose-Related Efficacy, Safety and Clinical Factors Associated with Response
por: Kim, Dong Wook, et al.
Publicado: (2022)

Low doses of amitriptyline, pregabalin, and gabapentin are preferred for management of neuropathic pain in India: is there a need for revisiting dosing recommendations?
por: Kamble, Sanjay Vasant, et al.
Publicado: (2017)

Comparative antiseizure medications of adjunctive treatment for children with drug-resistant focal-onset seizures: A systematic review and network meta-analysis
por: Zhang, Lanlan, et al.
Publicado: (2022)

A 16-year old male with cortical blindness and focal motor seizures
por: Katrak, S. M., et al.
Publicado: (2010)

Perampanel as First Add-On Therapy in Patients with Focal-Onset Seizures in the FAME Trial: Post hoc Analyses of Efficacy and Safety Related to Maintenance Dose and Background Antiepileptic Drug Therapy
por: Kim, Ji Hyun, et al.
Publicado: (2022)

Real‐world experience with direct brain‐responsive neurostimulation for focal onset seizures
por: Razavi, Babak, et al.
Publicado: (2020)

First add‐on perampanel for focal‐onset seizures: An open‐label, prospective study
por: Kim, Ji Hyun, et al.
Publicado: (2019)

Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland
por: Väätäinen, Saku, et al.
Publicado: (2019)

Brain Perfusion, Hippocampal Volumetric, and Diffusion-weighted Imaging Findings in Children with Prolonged Febrile Seizures and Focal Febrile Seizures
por: Rohilla, Seema, et al.
Publicado: (2021)

Basic PK/PD principles of drug effects in circular/proliferative systems for disease modelling
por: Jacqmin, Philippe, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_u8ktbb7mapidgi9o9s88no4n13